Pranil Chandra

508 total citations
19 papers, 305 citations indexed

About

Pranil Chandra is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Pranil Chandra has authored 19 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Pranil Chandra's work include Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (4 papers) and Acute Myeloid Leukemia Research (3 papers). Pranil Chandra is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (4 papers) and Acute Myeloid Leukemia Research (3 papers). Pranil Chandra collaborates with scholars based in United States, India and Canada. Pranil Chandra's co-authors include Gurdip S. Sidhu, Nicholas Cassai, Zhuang Zuo, Rajyalakshmi Luthra, L. Jeffrey Medeiros, Hartmut Koeppen, John Galbincea, Bedia A. Barkoh, Su S. Chen and Victoria M. Pratt and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Pranil Chandra

19 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pranil Chandra United States 8 116 95 81 52 49 19 305
Rena R. Xian United States 11 174 1.5× 114 1.2× 97 1.2× 119 2.3× 84 1.7× 42 401
Alexis Norris-Kirby United States 7 163 1.4× 184 1.9× 149 1.8× 96 1.8× 87 1.8× 7 490
Michael Svatoň Czechia 11 65 0.6× 84 0.9× 25 0.3× 85 1.6× 41 0.8× 23 315
YH Park South Korea 9 168 1.4× 81 0.9× 44 0.5× 24 0.5× 56 1.1× 34 367
Mary Lowery‐Nordberg United States 11 77 0.7× 117 1.2× 49 0.6× 52 1.0× 52 1.1× 19 288
Sebastian Ginzel Germany 11 85 0.7× 77 0.8× 40 0.5× 50 1.0× 11 0.2× 16 331
Minita Shah United States 9 67 0.6× 172 1.8× 87 1.1× 30 0.6× 54 1.1× 14 320
Antonio Martínez Spain 10 86 0.7× 96 1.0× 70 0.9× 19 0.4× 35 0.7× 18 441
Mary Lowery Nordberg United States 9 127 1.1× 161 1.7× 46 0.6× 76 1.5× 72 1.5× 26 390
Noah Kornblum United States 10 155 1.3× 133 1.4× 65 0.8× 19 0.4× 121 2.5× 52 384

Countries citing papers authored by Pranil Chandra

Since Specialization
Citations

This map shows the geographic impact of Pranil Chandra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pranil Chandra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pranil Chandra more than expected).

Fields of papers citing papers by Pranil Chandra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pranil Chandra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pranil Chandra. The network helps show where Pranil Chandra may publish in the future.

Co-authorship network of co-authors of Pranil Chandra

This figure shows the co-authorship network connecting the top 25 collaborators of Pranil Chandra. A scholar is included among the top collaborators of Pranil Chandra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pranil Chandra. Pranil Chandra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Carr, Ann G., et al.. (2025). Tumor diagnosis recharacterization enabled by comprehensive genomic profiling to guide precision medicine strategy. npj Precision Oncology. 9(1). 149–149. 2 indexed citations
2.
Sriram, Renuka, et al.. (2024). Genetic alterations in CDKN2A interacting network and their putative association with head and neck squamous cell carcinoma. Human Gene. 40. 201276–201276. 1 indexed citations
3.
Cushman‐Vokoun, Allison M., Josh Lauring, John D. Pfeifer, et al.. (2021). Laboratory and Clinical Implications of Incidental and Secondary Germline Findings During Tumor Testing. Archives of Pathology & Laboratory Medicine. 146(1). 70–77. 16 indexed citations
4.
Hagiwara, Kohei, Nathanael G. Bailey, Pranil Chandra, et al.. (2021). In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported. Blood Advances. 5(23). 5057–5059. 3 indexed citations
5.
Saltman, David L., Davide Salina, David R. Hout, et al.. (2021). Characterization of the tumor immune-microenvironment of adenocarcinoma of lung with a metastatic lesion in the pancreas treated successfully with first-line, single-agent pembrolizumab. Therapeutic Advances in Medical Oncology. 13. 4277422188–4277422188. 3 indexed citations
6.
Mukherjee, Sandeep, Scott R. Wheeler, Malini Sathanoori, et al.. (2016). Chromosomal microarray provides enhanced targetable gene aberration detection when paired with next generation sequencing panel in profiling lung and colorectal tumors. Cancer Genetics. 209(4). 119–129. 6 indexed citations
7.
Joseph, Loren, Milena Cankovic, Pranil Chandra, et al.. (2016). The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer. Journal of Molecular Diagnostics. 18(5). 605–619. 44 indexed citations
8.
Cohen, Daniel N., Aaron C. Shaver, Liping Du, et al.. (2015). Contribution of Beta-HPV Infection and UV Damage to Rapid-Onset Cutaneous Squamous Cell Carcinoma during BRAF-Inhibition Therapy. Clinical Cancer Research. 21(11). 2624–2634. 23 indexed citations
9.
Bauer, Todd M., David R. Spigel, Zeqiang Ma, et al.. (2014). Next-generation sequencing (NGS) in 936 patients (pts) with advanced cancers to prospectively guide clinical trial selection: The Sarah Cannon Research Institute (SCRI) experience.. Journal of Clinical Oncology. 32(15_suppl). 2534–2534. 1 indexed citations
10.
11.
Liang, Shile, Pranil Chandra, Zeqiang Ma, et al.. (2013). A community-based program for personalized cancer care using next-generation sequencing (NGS).. Journal of Clinical Oncology. 31(15_suppl). 11102–11102. 1 indexed citations
12.
Chandra, Pranil, Rajyalakshmi Luthra, Zhuang Zuo, et al.. (2010). Acute Myeloid Leukemia With t(9;11)(p21–22;q23). American Journal of Clinical Pathology. 133(5). 686–693. 19 indexed citations
13.
Zuo, Zhuang, Pranil Chandra, Yong Wen, & Hartmut Koeppen. (2009). Molecular diagnostics of acute myeloid leukaemia. Diagnostic histopathology. 15(11). 531–539. 1 indexed citations
14.
Zuo, Zhuang, Su S. Chen, Pranil Chandra, et al.. (2009). Application of COLD-PCR for improved detection of KRAS mutations in clinical samples. Modern Pathology. 22(8). 1023–1031. 100 indexed citations
15.
Chandra, Pranil, Jose A. Plaza, Zhuang Zuo, et al.. (2009). Clusterin Expression Correlates With Stage and Presence of Large Cells in Mycosis Fungoides. American Journal of Clinical Pathology. 131(4). 511–515. 6 indexed citations
16.
Chandra, Pranil, Yong Wen, Bruce G. Raphael, et al.. (2009). Postchemotherapy Histiocyte-Rich Pseudotumor Involving the Spleen. American Journal of Clinical Pathology. 132(3). 342–348. 10 indexed citations
17.
Bassermann, Florian, Pranil Chandra, Henrike K. Resemann, et al.. (2008). Ritonavir Sensitizes Multiple Myeloma Cells to Bortezomib-Induced Apoptosis. Blood. 112(11). 5194–5194. 1 indexed citations
18.
Schaffer, Julie V., Pranil Chandra, Brian R. Keegan, Patricia Heller, & Helen T. Shin. (2007). Widespread Granulomatous Dermatitis of Infancy. Archives of Dermatology. 143(3). 386–91. 15 indexed citations
19.
Sidhu, Gurdip S., Pranil Chandra, & Nicholas Cassai. (2005). Merkel Cells, Normal and Neoplastic: An Update. Ultrastructural Pathology. 29(3-4). 287–294. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rena R. Xian Breakdown of academic impact, for papers by Alexis Norris-Kirby Breakdown of academic impact, for papers by Michael Svatoň Breakdown of academic impact, for papers by YH Park Breakdown of academic impact, for papers by Mary Lowery‐Nordberg Breakdown of academic impact, for papers by Sebastian Ginzel Breakdown of academic impact, for papers by Minita Shah Breakdown of academic impact, for papers by Antonio Martínez Breakdown of academic impact, for papers by Mary Lowery Nordberg Breakdown of academic impact, for papers by Noah Kornblum
Rankless by CCL
2026